{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-092216","form_type":"8-K","ticker":"VSTM","cik":"0001526119","company_name":"Verastem, Inc.","filed_at":"2026-08-06T23:33:15+00:00","discovered_at":"2026-08-07T10:05:00.386959+00:00","generated_at":"2026-08-07T10:05:43.321915+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Verastem adds up to $75M Revenue Notes; $50M tranche set for Aug 28, 2026","bullets":["Amendment No. 3 creates new Revenue Notes series (up to $75M) replacing conditional $25M and $50M Initial Note tranches.","$50M tranche issues Aug 28, 2026; optional $25M tranche open until May 15, 2027 if quarterly avutometinib/defactinib net sales hit $40M.","Revenue Payment Percentage is 4.50%, falling to 1.75% after Dec 31, 2031 if cumulative payments reach 100% of Funded Amount; maturity June 30, 2033.","Repayment amounts range from 135% to 185% of Funded Amount depending on timing; up to 25% can be paid in VSTM common stock on US IP sale.","Initial Notes' $75M principal, 9.75% interest cap, and no financial covenants remain; obligations secured by substantially all assets."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-092216","json":"https://secwatch.observer/filing/0001104659-26-092216.json","markdown":"https://secwatch.observer/filing/0001104659-26-092216.md","text":"https://secwatch.observer/filing/0001104659-26-092216.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1526119/000110465926092216/0001104659-26-092216-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1526119/000110465926092216/tm2622452d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-07T10:05:43.321915+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}